EPHA4 and amyotrophic lateral sclerosis: A number of plasticity-promoting genetic or pharmacological strategies have proven successful in the past in ALS models, such as EphA4 knockdown and inhibition (Van Hoecke et al., 2012), and vascular endothelial growth factor (VEGF) administration in ALS rodents (Storkebaum et al., 2005).